• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡泊芬净与钙调神经磷酸酶途径抑制剂联合使用可减弱曲霉属真菌在体外的生长。

Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.

作者信息

Kontoyiannis Dimitrios P, Lewis Russell E, Osherov Nir, Albert Nathaniel D, May Gregory S

机构信息

Department of Infectious Diseases, Infection Control & Employee Health, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 402, Houston, TX 77030, USA.

出版信息

J Antimicrob Chemother. 2003 Feb;51(2):313-6. doi: 10.1093/jac/dkg090.

DOI:10.1093/jac/dkg090
PMID:12562696
Abstract

Work in Saccharomyces cerevisiae and Cryptococcus neoformans suggests that caspofungin could interact with the calcineurin pathway. We examined the in vitro interaction of caspofungin with calcineurin inhibitors (FK506, cyclosporin, FK520 and L685,818) and the TOR inhibitor rapamycin in 13 isolates of Aspergillus species. Caspofungin activity was enhanced by calcineurin/TOR inhibitors for all Aspergillus isolates studied. Further investigation of this pathway is warranted.

摘要

在酿酒酵母和新型隐球菌中的研究表明,卡泊芬净可能与钙调神经磷酸酶信号通路相互作用。我们检测了卡泊芬净与钙调神经磷酸酶抑制剂(FK506、环孢素、FK520和L685,818)以及雷帕霉素(一种TOR抑制剂)在13株曲霉菌分离株中的体外相互作用。对于所有研究的曲霉菌分离株,钙调神经磷酸酶/TOR抑制剂均可增强卡泊芬净的活性。有必要对该信号通路进行进一步研究。

相似文献

1
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.卡泊芬净与钙调神经磷酸酶途径抑制剂联合使用可减弱曲霉属真菌在体外的生长。
J Antimicrob Chemother. 2003 Feb;51(2):313-6. doi: 10.1093/jac/dkg090.
2
Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans.巴弗洛霉素A(1)、氟康唑以及棘白菌素MK-0991/醋酸卡泊芬净(L-743,873)与钙调神经磷酸酶抑制剂FK506和L-685,818对新型隐球菌的协同抗真菌活性。
Antimicrob Agents Chemother. 2000 Mar;44(3):739-46. doi: 10.1128/AAC.44.3.739-746.2000.
3
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.抗真菌药物与免疫抑制剂对烟曲霉的体外相互作用。
Antimicrob Agents Chemother. 2004 May;48(5):1664-9. doi: 10.1128/AAC.48.5.1664-1669.2004.
4
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.抗真菌药物与免疫抑制剂对来自移植患者和非移植患者的烟曲霉分离株的体外相互作用。
Antimicrob Agents Chemother. 2004 Dec;48(12):4922-5. doi: 10.1128/AAC.48.12.4922-4925.2004.
5
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.卡泊芬净与两性霉素B对曲霉属和镰刀菌属的体外协同作用
Antimicrob Agents Chemother. 2002 Jan;46(1):245-7. doi: 10.1128/AAC.46.1.245-247.2002.
6
In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis.体外研究卡泊芬净与免疫抑制剂对毛霉病病原体的相互作用。
J Antimicrob Chemother. 2011 Oct;66(10):2312-4. doi: 10.1093/jac/dkr297. Epub 2011 Jul 26.
7
Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus.钙调神经磷酸酶抑制或突变增强细胞壁抑制剂对烟曲霉的作用。
Antimicrob Agents Chemother. 2007 Aug;51(8):2979-81. doi: 10.1128/AAC.01394-06. Epub 2007 May 14.
8
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.卡泊芬净对曲霉菌和镰刀菌分离株的体外药敏试验方法。
Antimicrob Agents Chemother. 2001 Jan;45(1):327-30. doi: 10.1128/AAC.45.1.327-330.2001.
9
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.卡泊芬净与伊曲康唑对曲霉属的体外协同作用:最低抑菌浓度与最低有效浓度终点
Antimicrob Agents Chemother. 2003 Apr;47(4):1416-8. doi: 10.1128/AAC.47.4.1416-1418.2003.
10
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.醋酸卡泊芬净与伏立康唑对曲霉属临床分离株的体外相互作用
Antimicrob Agents Chemother. 2002 Sep;46(9):3039-41. doi: 10.1128/AAC.46.9.3039-3041.2002.

引用本文的文献

1
The cyclase-associated protein contributes to antifungal susceptibility and virulence in .环化酶相关蛋白有助于提高对真菌的易感性和毒力。
Emerg Microbes Infect. 2025 Dec;14(1):2506795. doi: 10.1080/22221751.2025.2506795. Epub 2025 Jun 9.
2
Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi.基于结构导向的C22和C32修饰FK520类似物的设计与合成及其对人类致病真菌活性的增强
Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2419883121. doi: 10.1073/pnas.2419883121. Epub 2024 Dec 31.
3
Potential Antifungal Targets for sp. from the Calcineurin and Heat Shock Protein Pathways.
丝孢酵母属潜在抗真菌靶点的钙调神经磷酸酶和热休克蛋白通路研究
Int J Mol Sci. 2022 Oct 19;23(20):12543. doi: 10.3390/ijms232012543.
4
Interactions of Antifungal Agents and Everolimus Against Species.抗真菌药物与依维莫司相互作用对 种的影响。
Front Cell Infect Microbiol. 2022 Jul 5;12:936814. doi: 10.3389/fcimb.2022.936814. eCollection 2022.
5
Therapeutic Approaches for Combating Associated Infection.对抗相关感染的治疗方法。
Curr Drug Targets. 2022;23(16):1465-1488. doi: 10.2174/1389450123666220623164548.
6
Drug repurposing strategies in the development of potential antifungal agents.药物重定位策略在潜在抗真菌药物开发中的应用。
Appl Microbiol Biotechnol. 2021 Jul;105(13):5259-5279. doi: 10.1007/s00253-021-11407-7. Epub 2021 Jun 21.
7
Puf4 Mediates Post-transcriptional Regulation of Cell Wall Biosynthesis and Caspofungin Resistance in Cryptococcus neoformans.Puf4 介导新生隐球菌细胞壁生物合成和卡泊芬净耐药的转录后调控。
mBio. 2021 Jan 12;12(1):e03225-20. doi: 10.1128/mBio.03225-20.
8
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens.FK506和雷帕霉素与机会性人类真菌病原体中FK506结合蛋白12的相互作用
Front Mol Biosci. 2020 Oct 16;7:588913. doi: 10.3389/fmolb.2020.588913. eCollection 2020.
9
Novel Antifungal Agents and Their Activity against Species.新型抗真菌药物及其对物种的活性。
J Fungi (Basel). 2020 Oct 9;6(4):213. doi: 10.3390/jof6040213.
10
Structure-guided approaches to targeting stress responses in human fungal pathogens.靶向人类真菌病原体应激反应的结构导向方法。
J Biol Chem. 2020 Oct 16;295(42):14458-14472. doi: 10.1074/jbc.REV120.013731. Epub 2020 Aug 12.